Low serum diamine oxidase (DAO) activity levels in patients with migraine.

dc.contributor.authorIzquierdo-Casas Joan
dc.contributor.authorComas Basté, Oriol
dc.contributor.authorLatorre Moratalla, Mariluz
dc.contributor.authorLorente-Gascón, Marian
dc.contributor.authorDuelo, Adriana
dc.contributor.authorVidal Carou, Ma. Carmen
dc.contributor.authorSoler-Singla, Luis
dc.date.accessioned2020-05-29T05:47:48Z
dc.date.available2020-05-29T05:47:48Z
dc.date.issued2017-06-17
dc.date.updated2020-05-29T05:47:49Z
dc.description.abstractHistamine intolerance is a disorder in the homeostasis of histamine due to a reduced intestinal degradation of this amine, mainly caused by a deficiency in the enzyme diamine oxidase (DAO). Among the several multifaced symptoms associated with histamine intolerance, headache is one of the most recognised and disabling consequences. The aim of this study was to determine the prevalence of DAO deficiency in patients with a confirmed migraine diagnosis according to the current International Headache Society (IHS) and in non-migraine subjects. DAO activity was assessed in a total of 198 volunteers recruited at the Headache Unit of the Hospital General de Catalunya, 137 in the migraine group and 61 as a control group. DAO enzyme activity in blood samples was determined by ELISA test. Values below 80 HDU/ml (Histamine Degrading Unit/ml) were considered as DAO deficient. Mean value of DAO activity from migraine population (64.5 ±33.5 HDU/ml) was significantly lower (p<0.0001) than that obtained from healthy volunteers (91.9 ± 44.3 HDU/ml). DAO deficiency was more prevalent in migraine patients than in the control group. A high incidence rate of DAO deficiency (87%) was observed in the group of patients with migraine. On the other hand, 44% of non-migranous subjects had levels of DAO activity lower than 80 HDU/ml. Despite the multifactorial etiology of migraine, these results seem to indicate that this enzymatic deficit could be related to the onset of migraine.
dc.format.extent7 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec674562
dc.identifier.issn1138-7548
dc.identifier.urihttps://hdl.handle.net/2445/162957
dc.language.isoeng
dc.publisherSpringer Verlag
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1007/s13105-017-0571-3
dc.relation.ispartofJournal of Physiology and Biochemistry, 2017, vol. 74, num. 1, p. 93-99
dc.relation.urihttps://doi.org/10.1007/s13105-017-0571-3
dc.rights(c) University of Navarra, 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Nutrició, Ciències de l'Alimentació i Gastronomia)
dc.subject.classificationMigranya
dc.subject.classificationDiamines
dc.subject.classificationEpidemiologia
dc.subject.classificationFisiologia patològica
dc.subject.classificationHistamina
dc.subject.classificationCefalàlgia
dc.subject.classificationEtiologia
dc.subject.classificationEspanya
dc.subject.otherMigraine
dc.subject.otherDiamines
dc.subject.otherEpidemiology
dc.subject.otherPathological physiology
dc.subject.otherHistamine
dc.subject.otherHeadache
dc.subject.otherEtiology
dc.subject.otherSpain
dc.titleLow serum diamine oxidase (DAO) activity levels in patients with migraine.
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
674562.pdf
Mida:
1009.83 KB
Format:
Adobe Portable Document Format